Vibha Jawa, PhD, chief scientific officer at EpiVax, explains why the need for animal studies varies by modality and what it takes for organ-on-chip and other human-relevant models to replace these studies in IND-enabling toxicology work.
|Articles|August 2, 2016
- Pharmaceutical Technology-08-02-2016
- Volume 40
- Issue 8
Sterile Bag Streamlines Environmental Monitoring Workflows
The IsoBag from MilliporeSigma is used for the convenient transfer of contact and settle plates to production isolators.
The IsoBag from MilliporeSigma is used for the convenient transfer of contact and settle plates to production isolators. The IsoBag offers a streamlined alternative for environmental monitoring and increases operation up-time by eliminating decontamination cycles. The bag allows for an uninterrupted workflow and is gamma-irradiated for immediate use. The IsoBag also includes sterile bags for safe transport of used plates.
Articles in this issue
about 10 years ago
Designing Flexible Aseptic Containment Systemsabout 10 years ago
Using 3D Printing for Solid-Dosage Drugsabout 10 years ago
One Strategy for Updating an Aging Facilityabout 10 years ago
Downstream Processing Continues to Worry CMOsabout 10 years ago
Quality Manufacturing Key to Stemming Drug Shortagesabout 10 years ago
New Equipment Meets Need for Innovation in Pharma Manufacturingabout 10 years ago
Evaluating Technology and Innovation in Biopharmaceutical Manufacturingabout 10 years ago
FDA and the Emerging Technology of 3D Printingabout 10 years ago
Measuring Equipment and Manufacturing Trendsabout 10 years ago
Manufacturing and Distribution Boundaries BlurRelated to this article
Sanjay Konagurthu, PhD, senior director of Science and Innovation at Thermo Fisher Scientific, explains what teams need to do to ensure the usefulness of AI and what strides have been made with AI in regulatory submissions.
Pauric Bannigan, Intrepid Labs, explains where AI speeds formulation decisions, why data is the bottleneck, and how active learning trains models with far less data.
The new initiative aims to apply traceable AI and science to expand care worldwide by translating discovery into tools that accelerate drug development.
Sanjay Konagurthu, PhD, senior director, Science and Innovation at Thermo Fisher Scientific, provides an update on the progress of AI and machine learning used in drug delivery.
Stephanie Johnson, Pfizer, explains how off-platform triggers, single-owner risk registers, and traceable prior knowledge keep protein formulation programs on track.
Stephanie Johnson, Pfizer, discusses how platform formulations moved 2 Pfizer protein programs to IND in 8 months by redistributing, not removing risk.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5